Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial

ConclusionsApheresis was well tolerated as maintenance therapy for UC although the cumulative clinical remission rate at 12  months was comparable between the apheresis and control groups.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research